AVTE Articles, Aerovate Therapeutics Inc. - From 07/08/24

WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (NASDAQ:AVTE), which previously announced it was halting enrollmen...

ATLANTA, June 21, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Aerovate Therapeutics, Inc. ("Aerovate"?or the "C...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 20, 2024 (GLOBE NEWSWIRE) -- The Por...

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Monday. The Dow traded up 0.57% to 38,807...

Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endp...

U.S. stocks traded mixed midway through trading, with the S&P 500 edging higher on Monday. The Dow traded up 0.08% to 38,618.63 while the NASDA...

BOSTON, June 17, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Aerovate Therapeutics, Inc. (NASDAQ:AVTE) for potential securitie...

Monday, Aerovate Therapeutics Inc (NASDAQ:AVTE) released topline results from the Phase 2b portion of the IMPAHCT Phase 2b/3 trial of AV-...

U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 100 points on Monday. Following the market opening Monday, the Do...

Baseline characteristics reflect a PAH population with significant disease Topline data from Phase 2b portion of IMPAHCT study to be released in J...